Internal Medicine, Gastroenterology · West Orange, NJ
NPI
1689774713
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
101 Old Short Hills Rd, Suite 217
West Orange, NJ, 07052
Phone (973) 731-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
1,579 services
Medicare patients, 2024
953
Average age 73
Drug cost, 2024
$438K
1,625 prescriptions
Company payments, 2025
$1,553
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert W Schuman was code 99214 (office e&m - established), 396 times for 289 patients. In total Robert W Schuman billed 1,579 services in 33 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 396 | 289 | $107.24 | $42K |
| 99213 Office E&M - Established | Office | 304 | 238 | $72.06 | $22K |
| 43239 Upper GI Endoscopy | Facility | 197 | 194 | $84.12 | $17K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 125 | 125 | $195.27 | $24K |
| 45380 Lower GI Endoscopy - Other | Facility | 106 | 106 | $156.11 | $17K |
| 45385 Colonoscopy - Lesion Removal | Facility | 102 | 102 | $230.17 | $23K |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 87 | 87 | $199.08 | $17K |
| 45378 Lower GI Endoscopy - Other | Facility | 69 | 69 | $153.66 | $11K |
| 99203 Office E&M - New | Office | 63 | 63 | $88.59 | $5,581 |
| 99204 Office E&M - New | Office | 49 | 49 | $122.49 | $6,002 |
| 99202 Office E&M - New | Office | 28 | 28 | $54.89 | $1,537 |
By year: 2022 $191K for 1,584 services; 2023 $183K for 1,511 services; 2024 $191K for 1,579 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert W Schuman prescribed most often to Medicare patients was Pantoprazole Sodium, with 290 prescriptions and refills. In total Robert W Schuman wrote 1,625 Medicare prescriptions that cost $438K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 290 | 847 | 137 | $5,142 |
| Omeprazole Generic | 161 | 465 | 79 | $2,758 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 108 | 108 | 107 | $17K |
| Famotidine Generic | 108 | 302 | 51 | $1,800 |
| Dicyclomine Hcl Generic | 91 | 160 | 58 | $2,327 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 87 | 87 | 87 | $12K |
| Sucralfate Generic | 64 | 95 | 23 | $14K |
| Esomeprazole Magnesium Generic | 55 | 139 | 19 | $1,805 |
| Creon Lipase/Protease/Amylase | 53 | 64 | 18 | $133K |
| Linzess Linaclotide | 47 | 101 | 17 | $52K |
| Mesalamine Generic | 35 | 73 | 12 | $13K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 32 | 36 | 12 | $587 |
| Metoclopramide Hcl Generic | 32 | 54 | 17 | $325 |
| Dexlansoprazole Dr Dexlansoprazole | 30 | 82 | 15 | $15K |
| Hydrocortisone Generic | 30 | 32 | 18 | $280 |
Brand drugs: - claims; generic drugs: 1,175 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert W Schuman $1,553 ($1,553 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $315.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $200 |
| Pfizer Inc. PFE | 9 | $147 |
| Janssen Biotech, Inc. JNJ | 8 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $136 |
| Celltrion USA Inc. 068270.KS | 5 | $85.13 |
| Evoke Pharma, Inc. EVOK | 4 | $75.17 |
| Lilly USA, LLC LLY | 4 | $68.67 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $50.49 |
| Ferring Pharmaceuticals Inc. | 2 | $46.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.